Comparison of facilities with and without additional medical fees for nutrition support team activity during the COVID-19 pandemic.

IF 1.2 Q4 PHARMACOLOGY & PHARMACY
Akihiko Futamura, Takenao Koseki, Junichi Iida, Akito Suzuki, Nobuyuki Muroi, Michiaki Myotoku, Hiroki Maki, Kazuhisa Mizutani, Hikaru Ogino, Yasuki Taniguchi, Keiichiro Higashi, Masanobu Usui
{"title":"Comparison of facilities with and without additional medical fees for nutrition support team activity during the COVID-19 pandemic.","authors":"Akihiko Futamura, Takenao Koseki, Junichi Iida, Akito Suzuki, Nobuyuki Muroi, Michiaki Myotoku, Hiroki Maki, Kazuhisa Mizutani, Hikaru Ogino, Yasuki Taniguchi, Keiichiro Higashi, Masanobu Usui","doi":"10.1186/s40780-024-00389-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study aimed to clarify the effectiveness of nutrition support team (NST) facilities for preventing central line-associated bloodstream infection (CLABSI).</p><p><strong>Methods: </strong>We retrospectively analyzed the incidence of CLABSI as well as the presence or absence of additional medical fees for NST activity between 2019 and 2021, including the period before and after the COVID-19 pandemic. Subsequently, we performed between-group comparisons of the CLABSI incidence. CLABSI rates were compared based on cumulative per 1000 catheter uses during the relevant period.</p><p><strong>Results: </strong>Among 47 facilities that were registered for participation, there were 34 and 13 facilities with and without additional medical fees for NST activity (NST and non-NST groups, respectively). The CLABSI incidence rate was significantly lower in the NST group 0.96 [0.28-1.73] than in the non-NST group 1.25 [075-6.10] (p < 0.05). Before the pandemic, the NST group had a lower CLABSI rate per 1000 catheter uses than the non-NST group 2019: 0.70 [0.12-1.26] vs 2.10 [0.62-5.97]. During the pandemic, the CLABSI incidence showed no significant between-group difference 2020: 0.99 [0.51-1.61] vs 1.01 [0.80-4.16]; 2021: 1.24 [0.44-2.35] vs 1.96 [1.23-5.31]; however, the CLABSI rates in the NST group remained low.</p><p><strong>Conclusion: </strong>During the COVID-19 pandemic, the incidence of CLABSI was lower in the NST group than in the non-NST group, indicating the effectiveness of NST in preventing the occurrence of CLABSI.</p>","PeriodicalId":16730,"journal":{"name":"Journal of Pharmaceutical Health Care and Sciences","volume":"10 1","pages":"67"},"PeriodicalIF":1.2000,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11529453/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Health Care and Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40780-024-00389-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: This study aimed to clarify the effectiveness of nutrition support team (NST) facilities for preventing central line-associated bloodstream infection (CLABSI).

Methods: We retrospectively analyzed the incidence of CLABSI as well as the presence or absence of additional medical fees for NST activity between 2019 and 2021, including the period before and after the COVID-19 pandemic. Subsequently, we performed between-group comparisons of the CLABSI incidence. CLABSI rates were compared based on cumulative per 1000 catheter uses during the relevant period.

Results: Among 47 facilities that were registered for participation, there were 34 and 13 facilities with and without additional medical fees for NST activity (NST and non-NST groups, respectively). The CLABSI incidence rate was significantly lower in the NST group 0.96 [0.28-1.73] than in the non-NST group 1.25 [075-6.10] (p < 0.05). Before the pandemic, the NST group had a lower CLABSI rate per 1000 catheter uses than the non-NST group 2019: 0.70 [0.12-1.26] vs 2.10 [0.62-5.97]. During the pandemic, the CLABSI incidence showed no significant between-group difference 2020: 0.99 [0.51-1.61] vs 1.01 [0.80-4.16]; 2021: 1.24 [0.44-2.35] vs 1.96 [1.23-5.31]; however, the CLABSI rates in the NST group remained low.

Conclusion: During the COVID-19 pandemic, the incidence of CLABSI was lower in the NST group than in the non-NST group, indicating the effectiveness of NST in preventing the occurrence of CLABSI.

在 COVID-19 大流行期间,对营养支持小组活动收取和不收取额外医疗费用的设施进行比较。
背景:本研究旨在阐明营养支持小组(NST)设施在预防中心静脉相关血流感染(CLABSI)方面的有效性:本研究旨在阐明营养支持小组(NST)设施在预防中心管路相关血流感染(CLABSI)方面的有效性:我们回顾性分析了 2019 年至 2021 年期间(包括 COVID-19 大流行前后)CLABSI 的发生率以及 NST 活动是否需要额外医疗费用。随后,我们对 CLABSI 发病率进行了组间比较。CLABSI 发生率根据相关期间每 1000 次导管使用的累积率进行比较:在登记参与的 47 家医疗机构中,分别有 34 家和 13 家医疗机构收取和未收取 NST 活动的额外医疗费用(NST 组和非 NST 组)。NST 组的 CLABSI 发生率为 0.96 [0.28-1.73] 明显低于非 NST 组的 1.25 [075-6.10] (p 结论:在 COVID-19 大流行期间,NST 组的 CLABSI 发生率为 0.96 [0.28-1.73] 明显低于非 NST 组的 1.25 [075-6.10] :在 COVID-19 大流行期间,NST 组的 CLABSI 发生率低于非 NST 组,表明 NST 能有效预防 CLABSI 的发生。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.80
自引率
0.00%
发文量
29
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信